Retina/Vitreous

Top Story

Nightstar initiates expansion study of NSR-RPGR for X-linked retinitis pigmentosa

November 21, 2018

First patient dosed in Adverum wet AMD gene therapy trial

November 21, 2018
The first patient has been dosed in a phase 1 trial of ADVM-022 gene therapy for wet age-related macular degeneration, Adverum Biotechnologies announced in a release…
In the Journals

Postnatal weight gain algorithm may help predict ROP risk

November 20, 2018
Postnatal weight gain may be a valid parameter to stratify infants at risk for developing retinopathy of prematurity, according to a study. More specifically, a weight…

Alcon, Verily shelve glucose-monitoring lens project

November 19, 2018
Alcon and Verily have suspended work on a glucose-sensing smart contact lens for patients with diabetes, according to a post on Verily’s website. The companies…
More Headlines »
Clinical Science Imaging

Enhanced Depth Imaging Optical Coherence Tomography: Choroidal Thickness and Correlations With Age, Refractive Error, and Axial Length

Ophthalmic Surgery, Lasers and Imaging Retina, July 2012, Volume 43 Issue 4
To evaluate choroidal thickness at five macular locations and assess the correlations between choroidal thickness at…
More »
CME

Innovative Targeting of IOP, Emerging New Science in Glaucoma Management

This activity is supported by an educational grant from Bausch + Lomb.

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people affected by the…
More »
Video From OSN Europe
Meeting News

VIDEO: Large cohort shows safety of Ozurdex for DME

October 8, 2018
More »

Nightstar initiates expansion study of NSR-RPGR for X-linked retinitis pigmentosa

November 21, 2018
Nightstar Therapeutics will begin a phase 2/3 expansion study of its gene therapy candidate for X-linked retinitis pigmentosa, according to a press…

First patient dosed in Adverum wet AMD gene therapy trial

November 21, 2018
The first patient has been dosed in a phase 1 trial of ADVM-022 gene therapy for wet age-related macular degeneration, Adverum Biotechnologies…

In the Journals

Postnatal weight gain algorithm may help predict ROP risk

November 20, 2018
Postnatal weight gain may be a valid parameter to stratify infants at risk for developing retinopathy of prematurity, according to a study. More…

Alcon, Verily shelve glucose-monitoring lens project

November 19, 2018
Alcon and Verily have suspended work on a glucose-sensing smart contact lens for patients with diabetes, according to a post on Verily’s…

OSN’s top news of the week

November 18, 2018
Here are the top stories of the past week on Healio.com/OSN:

In the Journals

Half-dose PDT resolves subretinal fluid in chronic central serous chorioretinopathy

November 16, 2018
Half-dose photodynamic therapy for the treatment of chronic central serous chorioretinopathy had superior results when compared with high-density…

Blog

BLOG: Artificial intelligence in early detection of wet AMD

November 16, 2018
It is crucial that we employ strategies to better detect intermediate age-related macular degeneration so we can begin treatment sooner and preserve…

In the Journals

Study finds predictors of visual outcomes following vitrectomy for macular hole

November 15, 2018
Poor preoperative visual acuity, perioperative complications, age-related macular degeneration and delay to surgery are significant predictors of…

Grand Rounds at the New England Eye Center

Woman presents with unilateral blurred vision and eye pain

Ocular Surgery News U.S. Edition, November 25, 2018
Omar Dajani, MD; Andre J. Witkin, MD
A 53-year-old Hispanic woman with a history of rheumatoid arthritis, iritis and a mechanical heart valve presented with complaints of blurry vision…

Artificial intelligence zeroes in on DR

Ocular Surgery News U.S. Edition, November 25, 2018
IDx-DR, an autonomous artificial intelligence-based diagnostic system for the detection of diabetic retinopathy in primary care offices, outperformed…

Practical concepts with the Argus II retinal prosthesis

November 14, 2018
There are revolutionary advances in surgery — radical shifts that change the trajectory of a field — and evolutionary changes, or more…

Zimura-Lucentis combination safe in wet AMD patients in phase 2a trial

November 13, 2018
Zimura, a complement factor C5 inhibitor, was found to be well tolerated in combination with Lucentis in a phase 2a clinical trial, Ophthotech…

Meeting NewsVideo

VIDEO: Sustained-release ranibizumab ‘exceeds expectations’ for wet AMD

November 9, 2018
CHICAGO — Carl D. Regillo, MD, gives an update on the phase 2 LADDER study, a four-arm trial of sustained-release ranibizumab (Genentech), at…

Meeting News

Repeated intravitreal sirolimus treatments improve vitreous haze

November 7, 2018
CHICAGO — The results of the integrated SAKURA program showed every-other-month dosing with intravitreal sirolimus improved ocular inflammation…

Compact Imaging, Novartis collaborate to develop home retinal monitoring system

November 7, 2018
Compact Imaging has signed a collaboration agreement with Novartis Pharma to develop a home-based monitor to detect progression of age-related…

Clearside’s retinal vein occlusion therapy fails to meet phase 3 endpoint

November 6, 2018
Xipere, an investigational treatment for retinal vein occlusion, did not achieve its phase 3 clinical trial primary endpoint, Clearside Biomedical…

Ophthotech acquires Versant Ventures-backed Inception 4

November 5, 2018
Ophthotech Corp. has acquired Inception 4 Inc. and its small molecule inhibitors of HtrA1, which are under development for the treatment of a range…

Meeting NewsVideo

VIDEO: Pearls on using the ForeseeHome to detect wet-AMD

November 5, 2018
CHICAGO — David S. Chin Yee, MD, discusses best practices in using the ForeseeHome device to monitor AMD patients' transition from dry to wet…

Meeting NewsVideo

VIDEO: Surgeons learning benefits of hypersonic vitrectomy

November 2, 2018
CHICAGO — At the American Academy of Ophthalmology meeting here, Carl C. Awh, MD, discusses some of the advantages surgeons are learning about…

ProQR granted license to Ionis’ retinitis pigmentosa candidate

November 2, 2018
ProQR Therapeutics has acquired worldwide licensing rights to Ionis Pharmaceuticals’ QR-1123, an RNA medicine for autosomal dominant retinitis…

More Headlines »